HER2 Testing in Breast Cancer: Improving IHC Performance

Описание к видео HER2 Testing in Breast Cancer: Improving IHC Performance

This virtual tumor board from ASCP will help you understand the latest evidence regarding HER2-low breast cancer, HER2 testing guidelines, the implications for the pathology team as HER2-low therapies emerge, and ways to streamline communications with oncologists and other members of the cancer care team. Claim CME/CMLE credit at https://store.ascp.org/productlisting.... Funded by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.

Комментарии

Информация по комментариям в разработке